Clinical Trial Update: Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating a closed-loop system for carbohydrate counting in Type 1 diabetes using weekly subcutaneous semaglutide is in Phase 2/3 and currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Type 1 Diabetes, Diabetes Mellitus | Phase 2, Phase 3 | Status: RECRUITING